TNON Stock Summary and Trading Ideas (Tenon Medical | NASDAQ:TNON)

Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Tenon Medical trades on the NASDAQ stock market under the symbol TNON.

As of September 18, 2026, TNON stock price declined to $4.08 with 348,007 million shares trading.

TNON has a beta of -1.44, meaning it tends to be less sensitive to market movements. TNON has a correlation of 0.02 to the broad based SPY ETF.

TNON has a market cap of $2.72 million. This is considered a Sub-Micro Cap stock.

Last quarter Tenon Medical reported $1 million in Revenue and -$12.35 earnings per share. This fell short of revenue expectation by $-261,000 and missed earnings estimates by -$3.95.

In the last 3 years, TNON traded as high as $1,316.00 and as low as $2.40.

The top ETF exchange traded funds that TNON belongs to (by Net Assets): VXF.

TNON has underperformed the market in the last year with a return of -90.6%, while the SPY ETF gained +16.8%. In the last 3 month period, TNON fell short of the market, returning -66.7%, while SPY returned +2.3%. However, in the most recent 2 weeks TNON has outperformed the stock market by returning +9.7%, while SPY returned -0.9%.

TNON support price is $3.56 and resistance is $4.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TNON shares will trade within this expected range on the day.